Cargando…

Direct and indirect cost of managing Alzheimer’s disease in the Islamic Republic of Iran

Background: Alzheimer’s disease (AD) affects a large number of adults annually all around the world. The monetary cost of this disorder is huge. This study aims to estimate the cost of AD in Iran by considering stages of disease. Methods: A cross-sectional study was designed from July to December 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aajami, Zahra, Kebriaeezadeh, Abbas, Nikfar, Shekoufeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626604/ https://www.ncbi.nlm.nih.gov/pubmed/31316730

Ejemplares similares

Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies
por: Rezvanfar, Mohammad Ali, et al.
Publicado: (2013)

A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience
por: Keshavarz, Khosro, et al.
Publicado: (2013)

Cost-effectiveness of adding-on new antiepileptic drugs to conventional regimens in controlling intractable seizures in children
por: Gharibnaseri, Zahra, et al.
Publicado: (2012)

Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran
por: Nikfar, Shekoufeh, et al.
Publicado: (2005)

Pharmacists Remuneration Models in Iran and Selected Countries: a Comparative Study
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2013)

Cost-utility of Protocols of BFM-ALL and UK-ALL for Treatment of Children with Acute Lymphoblastic Leukemia in Iran
por: HAYATI, Hadi, et al.
Publicado: (2018)

Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries
por: Kebriaeezadeh, Abbas, et al.
Publicado: (2013)

Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business?
por: Keshavarz, Khosro, et al.
Publicado: (2012)

Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2013)

Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study
por: Hashemi Meshkini, Amir, et al.
Publicado: (2012)

Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran
por: Teimouri, Fatemeh, et al.
Publicado: (2017)

Commercialization of biopharmaceutical knowledge in Iran; challenges and solutions
por: Nassiri-Koopaei, Nasser, et al.
Publicado: (2014)

The Projection of Burden of Disease in Islamic Republic of Iran to 2025
por: Khajehkazemi, Razieh, et al.
Publicado: (2013)

Health in the Islamic Republic of Iran, challenges and progresses
por: Lankarani, Kamran Bagheri, et al.
Publicado: (2013)

Gastroenterology and Hepatology Training in the Islamic Republic of Iran
por: Saberifiroozi, M, et al.
Publicado: (2011)

Islamic Republic of Iran’s Health System: Achievements and Prospective
por: Dastgerdi, M Vahid
Publicado: (2013)

A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With HBeAg-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision Model
por: Keshavarz, Khosro, et al.
Publicado: (2016)

Economic Burden of Hepatitis B Virus-Related Diseases: Evidence From Iran
por: Keshavarz, Khosro, et al.
Publicado: (2015)

A model for developing a decision support system to simulate national drug policy indicators
por: Abdollahiasl, Akbar, et al.
Publicado: (2011)

A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development
por: Goudarzi, Zahra, et al.
Publicado: (2021)

A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients With Chronic Hepatitis C Virus Genotype 1 Infection
por: Alavian, Seyed Moayed, et al.
Publicado: (2016)

A study of Happiness in the Islamic Republic of Iran’s work communities
por: Damari, Behzad, et al.
Publicado: (2021)

Designing and Launching Health Observatory Dashboard of Islamic Republic of Iran
por: Damari, Behzad, et al.
Publicado: (2022)

Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments
por: Nikfar, Shekoufeh, et al.
Publicado: (2013)

Cutaneous leishmaniasis situation analysis in the Islamic Republic of Iran in preparation for an elimination plan
por: Sharifi, Iraj, et al.
Publicado: (2023)

Consistent defined threshold and equity in health
por: Nikfar, Shekoufeh, et al.
Publicado: (2015)

Pharmacogenomics Implementation and Hurdles to Overcome; In the Context of a Developing Country
por: Ayati, Nayyereh, et al.
Publicado: (2021)

Improvement in Health Indicators of Islamic Republic of Iran in the Years 2004 and 2008
por: Goudarzi, S, et al.
Publicado: (2011)

How health transformation plan was designed and implemented in the Islamic Republic of Iran?
por: Harirchi, Iraj, et al.
Publicado: (2020)

32-Year Scientometric analysis of the Medical Journal of the Islamic Republic of Iran
por: Dehghanbanadaki, Hojat, et al.
Publicado: (2020)

Cladribine tablets are a cost-effective strategy in high-disease activity relapsing multiple sclerosis patients in Iran
por: Ayati, Nayyereh, et al.
Publicado: (2021)

Pattern of Antidepressant Utilization and Cost in Iran from 2006 to 2013 in Comparison with Other Countries
por: Soleymani, Fatemeh, et al.
Publicado: (2018)

The Prevalence of Gastroesophageal Reflux Disease (GERD) in the Islamic Republic of Iran: A Systematic Review
por: Delavari, Alireza, et al.
Publicado: (2012)

Conducting International Diploma Course on Leishmaniasis and Its Control in the Islamic Republic of Iran
por: Yaghoobi-Ershadi, Mohammad Reza, et al.
Publicado: (2019)

The United States of America and the Islamic Republic of Iran: the path to preventing traffic injuries?
por: Mokdad, Ali H
Publicado: (2010)

Quality of life in phenylketonuria (PKU) patients residing in Iehran, Islamic republic of Iran
por: Hatami, H, et al.
Publicado: (2015)

Survival of very preterm infants in the Islamic Republic of Iran: A population-based retrospective cohort study
por: Akrami, Forouzan, et al.
Publicado: (2021)

Primary Health Care Model for Non-Communicable Diseases Management during COVID-19 Pandemic in the Islamic Republic of Iran
por: Akrami, Forouzan, et al.
Publicado: (2022)

Direct and indirect cost of COVID-19 patients in Iran
por: Nakhaei, Karim, et al.
Publicado: (2021)

Direct and indirect medical costs of bladder cancer in Iran
por: Raadabadi, Mehdi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p2al9qjt2jfjmqa425un85ibba